Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen

Alternative dosage regimens for some anticancer therapies have been proposed in the midst of the SARS-COV-2 pandemic in order to protect the patients from attending to health care facilities. Flat-dosing of several immune-checkpoint inhibitors (ICIs), including nivolumab, have been established. Alth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Pous, Anna, Izquierdo, Cristina, Cucurull, Marc, Sánchez, Silvia, Lezcano, Clara, Domenech, Marta, Llobera, Laia, Plaja, Andrea, Moran, Teresa
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107731/
https://ncbi.nlm.nih.gov/pubmed/34012801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1315
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars